Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EFFERVESCENT: Valsartan in Carotid Atherosclerosis
NCT00208767Phase 2Completed
- Sponsor
- Emory University
- Start
- Feb 2005
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valsartan in atherosclerosis, carotid artery disease, sponsored by Emory University. Started Feb 2005; status: completed.
02
Drugs
valsartan
03
Conditions
atherosclerosiscarotid artery disease
Beyond the preview
Go deeper on NCT00208767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00208767.